glp 1 peer reviewed articles Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management GLP-1 Receptor Agonists for Obesity

Novo Nordisk and Eli Lilly are moving to end compounding of their medicines for good

We use carefully calibrated low doses as part of a holistic strategy that may support metabolic health while simultaneously addressing nutrition quality, movement patterns, hormonal balance, sleep optimization, stress management, and mindset

MOTS-C with repair peptides like BPC-157 or TB-500 makes sense if you're dealing with both metabolic goals and a tissue or gut issue

A full overview of available options can be found on the wellness injection menu

Lets explore some of the most effective options prescribed by our dermatologists